TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
DLB

Dolby Laboratories

Industrials · Specialty Business Services

57.50$ -2.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Dolby Laboratories (DLB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,349 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DLB
Line item 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
125 162 217 289 328 392 482 640 720 923 956 926 910 960 59 971 1,026 1,081 1,055 1,242 1,162 1,281 1,254 1,009 1,274 1,349
50 58 74 92 80 76 74 68 85 122 111 92 97 70 70 95 109 118 128 161 146 130 141 117 140 160
74 104 144 198 248 316 408 572 635 800 844 834 813 890 890 876 917 963 927 1,081 1,015 1,151 1,112 892 1,133 1,189
16 15 18 23 31 35 44 62 67 105 124 140 169 183 183 201 220 233 237 238 239 254 261 201 264 262
95 130 135 154 179 224 106 119 138 149 162 178 0.0 182 169 172 197 205 220 224 275 192 270 287
64 15 95 130 166 190 223 286 292 354 411 471 562 614 662 684 702 744 787 795 810 895 656 869 924
9.9 0.5 48 68 82 126 185 286 342 446 433 363 251 276 274 214 233 261 183 294 221 341 217 219 265 265
3.4 0.6 2.1 2.3 1.9 1.8 3.1 2.1 0.9 0.7 1.0 0.2 0.6 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.2 0.5 0.4 0.2 34
6.5 -0.2 48 68 91 147 209 302 371 437 441 369 251 276 0.0 246 236 257 196 282 240 355 215 241 312 303
4.2 0.0 16 27 37 56 65 101 127 154 130 104 60 67 67 63 50 54 154 27 8.1 37 31 -49 48 47
5.7 -0.1 31 40 52 90 143 199 243 283 309 264 189 206 206 181 186 202 42 255 231 310 184 191 262 255
9.9 89 57 79 104 161 227 329 401 473 485 413 304 329 315 321 341 278 367 331 450 319 219 400 379

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?